|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/51 | (2006.01) |
| A61K 31/337 | (2006.01) | ||
| A61K 47/42 | (2017.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2117520 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07862937.5 |
| Date of filing the European patent application | 2007-12-14 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (86) | Number | PCT/US2007/025645 |
| Date | 2007-12-14 |
| (87) | Number | WO 2008/076373 |
| Date | 2008-06-26 |
| (30) | Number | Date | Country code |
| 875004 P | 2006-12-14 | US |
| (72) |
DESAI, Neil P., US
SOON-SHIONG, Patrick, US
|
| (73) |
Abraxis BioScience, LLC,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Krūties vėžio terapija hormonų receptoriaus statuso pagrindu su nanodalelėmis, apimančiomis taksaną |
| BREAST CANCER THERAPY BASED ON HORMONE RECEPTOR STATUS WITH NANOPARTICLES COMPRISING TAXANE |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 18 | 347.00 EUR |
| 2025-12-14 |